Evidence map›Paper›PMID 36190404›Full record

ArticleMicrobiology spectrum2022

Marta Palau, Estela Muñoz, Enric Lujan, Nieves Larrosa, Xavier Gomis, Ester Márquez, Oscar Len, Benito Almirante, Jordi Abellà, Sergi Colominas and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Marta Palau *Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-4567-9868
Estela Muñoz *Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-6693-4987
Enric LujanElectrochemical Methods Laboratory-Analytical and Applied Chemistry Department, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain.ORCID 0000-0003-2438-6123
Nieves LarrosaSpanish Network for Research in Infectious Diseases (REIPI RD19/0016), Instituto de Salud Carlos III, Madrid, Spain.ORCID 0000-0001-8808-0233
Xavier GomisAntibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0001-6258-3721
Ester MárquezInfectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-9824-0138
Oscar LenAntibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-1819-3141
Benito AlmiranteAntibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-1189-2361
Jordi AbellàElectrochemical Methods Laboratory-Analytical and Applied Chemistry Department, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain.ORCID 0000-0002-5854-7514
Sergi Colominas *Electrochemical Methods Laboratory-Analytical and Applied Chemistry Department, IQS School of Engineering, Universitat Ramon Llull, Barcelona, Spain.ORCID 0000-0002-7678-2489
Joan Gavaldà *Antibiotic Resistance Laboratory, Vall d'Hebron Research Institute (VHIR), Infectious Diseases Department, Vall d'Hebron University Hospital, Barcelona, Spain.ORCID 0000-0002-9829-3141
Instituto de Salud Carlos III · ESUniversitat Ramon Llull · ESVall d'Hebron Hospital Universitari · ESVall d'Hebron Institut de Recerca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aims of this study were as follows. First, we determined the antimicrobial efficacy of hypochlorous acid (HClO) against bacterial, fungal, and yeast strains growing planktonically and growing in biofilms. Second, we sought to compare the activity of the combination of daptomycin and HClO versus those of the antimicrobial agents alone for the treatment of experimental catheter-related Staphylococcus epidermidis infection (CRI) using the antibiotic lock technique (ALT) in a rabbit model. HClO was generated through direct electric current (DC) shots at determined amperages and times. For planktonic susceptibility studies, 1 to 3 DC shots of 2, 5, and 10 mA from 0 to 300 s were applied. A DC shot of 20 mA from 0 to 20 min was applied to biofilm-producing strains. Central venous catheters were inserted into New Zealand White rabbits, inoculated with an S. epidermidis strain, and treated with saline solution or ALT using daptomycin (50 mg/mL), HClO (20 mA for 45 min), or daptomycin plus HClO. One hundred percent of the planktonic bacterial, fungal, and yeast strains were killed by applying one DC shot of 2, 5, and 10 mA, respectively. One DC shot of 20 mA for 20 min was sufficient to eradicate 100% of the tested biofilm-producing strains. Daptomycin plus HClO lock therapy showed the highest activity for experimental CRI with S. epidermidis. HClO could be an effective strategy for treating infections caused by extensively drug-resistant or multidrug-resistant and biofilm-producing strains in medical devices and chronic wounds. The results of the ALT using daptomycin plus HClO may be promising.

Indexed as

Anti-Infective AgentsCatheter-Related InfectionsDaptomycinAnimalsAnti-Bacterial AgentsBiofilmsHypochlorous AcidMicrobial Sensitivity TestsRabbitsSaccharomyces cerevisiaeSaline SolutionStaphylococcus epidermidisVancomycinAnti-Bacterial AgentsAnti-Infective AgentsDaptomycinHypochlorous AcidSaline SolutionVancomycinA. fumigatusantibiotic lock techniquebiofilmsCandida spp.catheter-related infectionHClOMDR bacteriaXDR bacteria

Identifiers

PMID36190404
PMCPMC9602778
OpenAlexW4300688218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.